[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Liposome Drug Delivery Market Report 2018

March 2018 | 108 pages | ID: U6AFE7755DCEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Liposome Drug Delivery market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Liposome Drug Delivery in these regions, from 2013 to 2025 (forecast).
United States Liposome Drug Delivery market competition by top manufacturers/players, with Liposome Drug Delivery sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Johnson & Johnson
  • Gilead Sciences
  • Pacira
  • Sun Pharmaceutical
  • Luye Pharma
  • Sigma-Tau Group
  • Fudan-Zhangjiang
  • Teva Pharmaceutical
  • CSPC
  • Novartis
  • Kingond Pharm
  • Spectrum Pharmaceuticals
  • Shanghai New Asia
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Liposomal Doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Cancer & Tumor Therapy
  • Fungal Infection Therapy
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Liposome Drug Delivery Market Report 2018

1 LIPOSOME DRUG DELIVERY OVERVIEW

1.1 Product Overview and Scope of Liposome Drug Delivery
1.2 Classification of Liposome Drug Delivery by Product Category
  1.2.1 United States Liposome Drug Delivery Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Liposome Drug Delivery Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Liposomal Doxorubicin
  1.2.4 Liposomal Amphoteracin B
  1.2.5 Liposomal Paclitaxel
  1.2.6 Others
1.3 United States Liposome Drug Delivery Market by Application/End Users
  1.3.1 United States Liposome Drug Delivery Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Cancer & Tumor Therapy
  1.3.3 Fungal Infection Therapy
  1.3.4 Others
1.4 United States Liposome Drug Delivery Market by Region
  1.4.1 United States Liposome Drug Delivery Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Liposome Drug Delivery Status and Prospect (2013-2025)
  1.4.3 Southwest Liposome Drug Delivery Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Liposome Drug Delivery Status and Prospect (2013-2025)
  1.4.5 New England Liposome Drug Delivery Status and Prospect (2013-2025)
  1.4.6 The South Liposome Drug Delivery Status and Prospect (2013-2025)
  1.4.7 The Midwest Liposome Drug Delivery Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Liposome Drug Delivery (2013-2025)
  1.5.1 United States Liposome Drug Delivery Sales and Growth Rate (2013-2025)
  1.5.2 United States Liposome Drug Delivery Revenue and Growth Rate (2013-2025)

2 UNITED STATES LIPOSOME DRUG DELIVERY MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Liposome Drug Delivery Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Liposome Drug Delivery Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Liposome Drug Delivery Average Price by Players/Suppliers (2013-2018)
2.4 United States Liposome Drug Delivery Market Competitive Situation and Trends
  2.4.1 United States Liposome Drug Delivery Market Concentration Rate
  2.4.2 United States Liposome Drug Delivery Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Liposome Drug Delivery Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LIPOSOME DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Liposome Drug Delivery Sales and Market Share by Region (2013-2018)
3.2 United States Liposome Drug Delivery Revenue and Market Share by Region (2013-2018)
3.3 United States Liposome Drug Delivery Price by Region (2013-2018)

4 UNITED STATES LIPOSOME DRUG DELIVERY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Liposome Drug Delivery Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Liposome Drug Delivery Revenue and Market Share by Type (2013-2018)
4.3 United States Liposome Drug Delivery Price by Type (2013-2018)
4.4 United States Liposome Drug Delivery Sales Growth Rate by Type (2013-2018)

5 UNITED STATES LIPOSOME DRUG DELIVERY SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Liposome Drug Delivery Sales and Market Share by Application (2013-2018)
5.2 United States Liposome Drug Delivery Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES LIPOSOME DRUG DELIVERY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Johnson & Johnson
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Liposome Drug Delivery Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Gilead Sciences
  6.2.2 Liposome Drug Delivery Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Pacira
  6.3.2 Liposome Drug Delivery Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pacira Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Sun Pharmaceutical
  6.4.2 Liposome Drug Delivery Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Luye Pharma
  6.5.2 Liposome Drug Delivery Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Sigma-Tau Group
  6.6.2 Liposome Drug Delivery Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sigma-Tau Group Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Fudan-Zhangjiang
  6.7.2 Liposome Drug Delivery Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceutical
  6.8.2 Liposome Drug Delivery Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 CSPC
  6.9.2 Liposome Drug Delivery Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 CSPC Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Novartis
  6.10.2 Liposome Drug Delivery Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis Liposome Drug Delivery Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Kingond Pharm
6.12 Spectrum Pharmaceuticals
6.13 Shanghai New Asia

7 LIPOSOME DRUG DELIVERY MANUFACTURING COST ANALYSIS

7.1 Liposome Drug Delivery Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Liposome Drug Delivery

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Liposome Drug Delivery Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Liposome Drug Delivery Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LIPOSOME DRUG DELIVERY MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Liposome Drug Delivery Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Liposome Drug Delivery Sales Volume Forecast by Type (2018-2025)
11.3 United States Liposome Drug Delivery Sales Volume Forecast by Application (2018-2025)
11.4 United States Liposome Drug Delivery Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Liposome Drug Delivery
Figure United States Liposome Drug Delivery Market Size (K Vials) by Type (2013-2025)
Figure United States Liposome Drug Delivery Sales Volume Market Share by Type (Product Category) in 2017
Figure Liposomal Doxorubicin Product Picture
Figure Liposomal Amphoteracin B Product Picture
Figure Liposomal Paclitaxel Product Picture
Figure Others Product Picture
Figure United States Liposome Drug Delivery Market Size (K Vials) by Application (2013-2025)
Figure United States Sales Market Share of Liposome Drug Delivery by Application in 2017
Figure Cancer & Tumor Therapy Examples
Table Key Downstream Customer in Cancer & Tumor Therapy
Figure Fungal Infection Therapy Examples
Table Key Downstream Customer in Fungal Infection Therapy
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Liposome Drug Delivery Market Size (Million USD) by Region (2013-2025)
Figure The West Liposome Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Liposome Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Liposome Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Liposome Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Liposome Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Liposome Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Liposome Drug Delivery Sales (K Vials) and Growth Rate (2013-2025)
Figure United States Liposome Drug Delivery Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Liposome Drug Delivery Market Major Players Product Sales Volume (K Vials) (2013-2018)
Table United States Liposome Drug Delivery Sales (K Vials) of Key Players/Suppliers (2013-2018)
Table United States Liposome Drug Delivery Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Liposome Drug Delivery Sales Share by Players/Suppliers
Figure 2017 United States Liposome Drug Delivery Sales Share by Players/Suppliers
Figure United States Liposome Drug Delivery Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Liposome Drug Delivery Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Liposome Drug Delivery Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Liposome Drug Delivery Revenue Share by Players/Suppliers
Figure 2017 United States Liposome Drug Delivery Revenue Share by Players/Suppliers
Table United States Market Liposome Drug Delivery Average Price (USD/Vial) of Key Players/Suppliers (2013-2018)
Figure United States Market Liposome Drug Delivery Average Price (USD/Vial) of Key Players/Suppliers in 2017
Figure United States Liposome Drug Delivery Market Share of Top 3 Players/Suppliers
Figure United States Liposome Drug Delivery Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Liposome Drug Delivery Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Liposome Drug Delivery Product Category
Table United States Liposome Drug Delivery Sales (K Vials) by Region (2013-2018)
Table United States Liposome Drug Delivery Sales Share by Region (2013-2018)
Figure United States Liposome Drug Delivery Sales Share by Region (2013-2018)
Figure United States Liposome Drug Delivery Sales Market Share by Region in 2017
Table United States Liposome Drug Delivery Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Liposome Drug Delivery Revenue Share by Region (2013-2018)
Figure United States Liposome Drug Delivery Revenue Market Share by Region (2013-2018)
Figure United States Liposome Drug Delivery Revenue Market Share by Region in 2017
Table United States Liposome Drug Delivery Price (USD/Vial) by Region (2013-2018)
Table United States Liposome Drug Delivery Sales (K Vials) by Type (2013-2018)
Table United States Liposome Drug Delivery Sales Share by Type (2013-2018)
Figure United States Liposome Drug Delivery Sales Share by Type (2013-2018)
Figure United States Liposome Drug Delivery Sales Market Share by Type in 2017
Table United States Liposome Drug Delivery Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Liposome Drug Delivery Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Liposome Drug Delivery by Type (2013-2018)
Figure Revenue Market Share of Liposome Drug Delivery by Type in 2017
Table United States Liposome Drug Delivery Price (USD/Vial) by Types (2013-2018)
Figure United States Liposome Drug Delivery Sales Growth Rate by Type (2013-2018)
Table United States Liposome Drug Delivery Sales (K Vials) by Application (2013-2018)
Table United States Liposome Drug Delivery Sales Market Share by Application (2013-2018)
Figure United States Liposome Drug Delivery Sales Market Share by Application (2013-2018)
Figure United States Liposome Drug Delivery Sales Market Share by Application in 2017
Table United States Liposome Drug Delivery Sales Growth Rate by Application (2013-2018)
Figure United States Liposome Drug Delivery Sales Growth Rate by Application (2013-2018)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Liposome Drug Delivery Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2013-2018)
Figure Johnson & Johnson Liposome Drug Delivery Sales Growth Rate (2013-2018)
Figure Johnson & Johnson Liposome Drug Delivery Sales Market Share in United States (2013-2018)
Figure Johnson & Johnson Liposome Drug Delivery Revenue Market Share in United States (2013-2018)
Table Gilead Sciences Basic Information List
Table Gilead Sciences Liposome Drug Delivery Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2013-2018)
Figure Gilead Sciences Liposome Drug Delivery Sales Growth Rate (2013-2018)
Figure Gilead Sciences Liposome Drug Delivery Sales Market Share in United States (2013-2018)
Figure Gilead Sciences Liposome Drug Delivery Revenue Market Share in United States (2013-2018)
Table Pacira Basic Information List
Table Pacira Liposome Drug Delivery Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2013-2018)
Figure Pacira Liposome Drug Delivery Sales Growth Rate (2013-2018)
Figure Pacira Liposome Drug Delivery Sales Market Share in United States (2013-2018)
Figure Pacira Liposome Drug Delivery Revenue Market Share in United States (2013-2018)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Liposome Drug Delivery Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2013-2018)
Figure Sun Pharmaceutical Liposome Drug Delivery Sales Growth Rate (2013-2018)
Figure Sun Pharmaceutical Liposome Drug Delivery Sales Market Share in United States (2013-2018)
Figure Sun Pharmaceutical Liposome Drug Delivery Revenue Market Share in United States (2013-2018)
Table Luye Pharma Basic Information List
Table Luye Pharma Liposome Drug Delivery Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2013-2018)
Figure Luye Pharma Liposome Drug Delivery Sales Growth Rate (2013-2018)
Figure Luye Pharma Liposome Drug Delivery Sales Market Share in United States (2013-2018)
Figure Luye Pharma Liposome Drug Delivery Revenue Market Share in United States (2013-2018)
Table Sigma-Tau Group Basic Information List
Table Sigma-Tau Group Liposome Drug Delivery Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2013-2018)
Figure Sigma-Tau Group Liposome Drug Delivery Sales Growth Rate (2013-2018)
Figure Sigma-Tau Group Liposome Drug Delivery Sales Market Share in United States (2013-2018)
Figure Sigma-Tau Group Liposome Drug Delivery Revenue Market Share in United States (2013-2018)
Table Fudan-Zhangjiang Basic Information List
Table Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2013-2018)
Figure Fudan-Zhangjiang Liposome Drug Delivery Sales Growth Rate (2013-2018)
Figure Fudan-Zhangjiang Liposome Drug Delivery Sales Market Share in United States (2013-2018)
Figure Fudan-Zhangjiang Liposome Drug Delivery Revenue Market Share in United States (2013-2018)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical Liposome Drug Delivery Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2013-2018)
Figure Teva Pharmaceutical Liposome Drug Delivery Sales Growth Rate (2013-2018)
Figure Teva Pharmaceutical Liposome Drug Delivery Sales Market Share in United States (2013-2018)
Figure Teva Pharmaceutical Liposome Drug Delivery Revenue Market Share in United States (2013-2018)
Table CSPC Basic Information List
Table CSPC Liposome Drug Delivery Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2013-2018)
Figure CSPC Liposome Drug Delivery Sales Growth Rate (2013-2018)
Figure CSPC Liposome Drug Delivery Sales Market Share in United States (2013-2018)
Figure CSPC Liposome Drug Delivery Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Liposome Drug Delivery Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2013-2018)
Figure Novartis Liposome Drug Delivery Sales Growth Rate (2013-2018)
Figure Novartis Liposome Drug Delivery Sales Market Share in United States (2013-2018)
Figure Novartis Liposome Drug Delivery Revenue Market Share in United States (2013-2018)
Table Kingond Pharm Basic Information List
Table Spectrum Pharmaceuticals Basic Information List
Table Shanghai New Asia Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Liposome Drug Delivery
Figure Manufacturing Process Analysis of Liposome Drug Delivery
Figure Liposome Drug Delivery Industrial Chain Analysis
Table Raw Materials Sources of Liposome Drug Delivery Major Players/Suppliers in 2017
Table Major Buyers of Liposome Drug Delivery
Table Distributors/Traders List
Figure United States Liposome Drug Delivery Sales Volume (K Vials) and Growth Rate Forecast (2018-2025)
Figure United States Liposome Drug Delivery Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Liposome Drug Delivery Price (USD/Vial) Trend Forecast (2018-2025)
Table United States Liposome Drug Delivery Sales Volume (K Vials) Forecast by Type (2018-2025)
Figure United States Liposome Drug Delivery Sales Volume (K Vials) Forecast by Type (2018-2025)
Figure United States Liposome Drug Delivery Sales Volume (K Vials) Forecast by Type in 2025
Table United States Liposome Drug Delivery Sales Volume (K Vials) Forecast by Application (2018-2025)
Figure United States Liposome Drug Delivery Sales Volume (K Vials) Forecast by Application (2018-2025)
Figure United States Liposome Drug Delivery Sales Volume (K Vials) Forecast by Application in 2025
Table United States Liposome Drug Delivery Sales Volume (K Vials) Forecast by Region (2018-2025)
Table United States Liposome Drug Delivery Sales Volume Share Forecast by Region (2018-2025)
Figure United States Liposome Drug Delivery Sales Volume Share Forecast by Region (2018-2025)
Figure United States Liposome Drug Delivery Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories